- •Preface
- •Acknowledgments
- •Contents
- •E. Secondary active transport
- •B. Steps in excitation–contraction coupling in smooth muscle (Figure 1.16)
- •Answers and Explanations
- •D. Effects of the ANS on various organ systems (Table 2.4)
- •Answers and Explanations
- •B. Velocity of blood flow
- •D. Resistance
- •F. Pressure profile in blood vessels
- •H. Venous pressure
- •B. Cardiac action potentials (see Table 1.3)
- •F. Cardiac and vascular function curves (Figure 3.11)
- •I. Cardiac oxygen (O2) consumption
- •C. Fluid exchange across capillaries
- •A. Local (intrinsic) control of blood flow
- •Answers and Explanations
- •C. Forced expiratory volume (FEV1) (Figure 4.2)
- •C. Compliance of the respiratory system
- •A. Central control of breathing (brain stem and cerebral cortex)
- •Answers and Explanations
- •D. Free-water clearance (CH2O)
- •E. Clinical disorders related to the concentration or dilution of urine (Table 5.6)
- •Answers and Explanations
- •C. Pancreatic secretion
- •A. Bile formation and secretion (see IV D)
- •Answers and Explanations
- •A. G proteins
- •B. Adrenal medulla (see Chapter 2, I A 4)
- •D. Somatostatin
- •C. Actions of estrogen
- •Answers and Explanations
- •Answers and Explanations
|
|
|
|
Endocrine Physiology |
259 |
|||||
|
Chapter 7 |
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cholesterol |
LH (theca cells) |
||||||
|
|
|
|
+ |
|
|
|
|
||
|
|
|
|
|
|
|
|
Progesterone |
||
|
|
|
Pregnenolone |
|
|
|
||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|||
|
|
17-Hydroxypregnenolone |
|
|
||||||
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|||
|
|
Dehydroepiandrosterone |
|
|
||||||
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
||
|
|
Androstenedione |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Testosterone |
|
|
|
FSH |
|||
|
|
|
|
|
aromatase |
|
|
|
+ |
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
(granulosa cells) |
|
||||
fIGUre 7.18 Synthesis of estrogen and progesterone. FSH = |
|
17β-Estradiol |
|
|
|
|
||||
follicle-stimulating hormone; LH = luteinizing hormone. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.Anterior lobe of the pituitary—fsH and lH
■ FSH and LH stimulate the following in the ovaries:
a.Steroidogenesis in the ovarian follicle and corpus luteum
b.Follicular development beyond the antral stage
c.Ovulation
d.Luteinization
3.negative and positive feedback control—estrogen and progesterone (Table 7.13)
C. Actions of estrogen
1.Has both negative and positive feedback effects on FSH and LH secretion.
2.Causes maturation and maintenance of the fallopian tubes, uterus, cervix, and vagina.
3.Causes the development of female secondary sex characteristics at puberty.
4.Causes the development of the breasts.
5.Up-regulates estrogen, LH, and progesterone receptors.
6.Causes proliferation and development of ovarian granulosa cells.
7.Maintains pregnancy.
|
|
|
|
|
t a b l e |
7.13 |
Negative and Positive Feedback Control of the |
||
|
|
Menstrual Cycle |
|
|
|
|
|
|
|
Phase of menstrual Cycle |
Hormone |
Type of feedback and site |
||
|
|
|
|
|
Follicular |
|
Estrogen |
Negative; anterior pituitary |
|
Midcycle |
|
Estrogen |
Positive; anterior pituitary |
|
Luteal |
|
Estrogen |
Negative; anterior pituitary |
|
|
|
Progesterone |
Negative; anterior pituitary |
|
260 BRS Physiology
8. Lowers the uterine threshold to contractile stimuli during pregnancy. 9. Stimulates prolactin secretion (but then blocks its action on the breast).
D.Actions of progesterone
1. Has negative feedback effects on FSH and LH secretion during luteal phase. 2. Maintains secretory activity of the uterus during the luteal phase.
3. Maintains pregnancy.
4. Raises the uterine threshold to contractile stimuli during pregnancy. 5. Participates in development of the breasts.
E.Menstrual cycle (Figure 7.19)
1. Follicular phase (days 0 to 14)
■A primordial follicle develops to the graafian stage, with atresia of neighboring follicles.
■LH and FSH receptors are up-regulated in theca and granulosa cells.
■Estradiol levels increase and cause proliferation of the uterus.
■FSH and LH levels are suppressed by the negative feedback effect of estradiol on the anterior pituitary.
■Progesterone levels are low.
|
|
|
|
|
|
Ovulation |
|
|
|
|
|
|
|
Follicular phase |
Luteal phase |
|
|
|
|
||||
|
|
Basal body |
|
|
Progesterone |
|
|
|
|
||
|
|
temperature |
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
17β-Estradiol |
|
|
|
|
|
|
|
|
|
|
|
LH |
|
|
|
|
|
menses |
|
|
|
FSH |
menses |
|
||||
24 26 |
0 |
2 |
4 |
6 |
8 |
10 12 14 16 18 20 22 24 26 |
0 |
2 |
4 |
Figure 7.19 The menstrual cycle. FSH |
|
|
|
|
|
|
|
Day of cycle |
|
|
|
||
|
|
|
|
|
|
|
|
|
= follicle-stimulating hormone; LH = |
||
|
|
|
|
|
|
|
|
|
|
|
luteinizing hormone. |
|
Endocrine Physiology |
261 |
Chapter 7 |
2. Ovulation (day 14)
■occurs 14 days before menses, regardless of cycle length. Thus, in a 28-day cycle, ovulation occurs on day 14; in a 35-day cycle, ovulation occurs on day 22.
■A burst of estradiol synthesis at the end of the follicular phase has a positive feedback effect on the secretion of FSH and LH (LH surge).
■Ovulation occurs as a result of the estrogen-induced LH surge.
■Estrogen levels decrease just after ovulation (but rise again during the luteal phase).
■Cervical mucus increases in quantity; it becomes less viscous and more penetrable by sperm.
3. Luteal phase (days 14 to 28)
■The corpus luteum begins to develop, and it synthesizes estrogen and progesterone.
■Vascularity and secretory activity of the endometrium increase to prepare for receipt of a fertilized egg.
■Basal body temperature increases because of the effect of progesterone on the hypothalamic thermoregulatory center.
■If fertilization does not occur, the corpus luteum regresses at the end of the luteal phase. As a result, estradiol and progesterone levels decrease abruptly.
4. Menses (days 0 to 4)
■The endometrium is sloughed because of the abrupt withdrawal of estradiol and progesterone.
F.Pregnancy (Figure 7.20)
■is characterized by steadily increasing levels of estrogen and progesterone, which maintain the endometrium for the fetus, suppress ovarian follicular function (by inhibiting FSH and LH secretion), and stimulate development of the breasts.
1. Fertilization
■If fertilization occurs, the corpus luteum is rescued from regression by human chorionic gonadotropin (HCG), which is produced by the placenta.
Figure 7.20 Hormone levels during pregnancy. HCG = human chorionic gonadotropin; HPL = human placental lactogen.
level |
|
HPL |
|
|
Progesterone |
|
|
Hormone |
|
|
|
|
Estriol |
|
|
|
|
|
|
10 |
20 |
30 |
40 |
|
Weeks of pregnancy |
|
|
Corpus |
|
Placenta |
|
luteum |
|
|
|
262 |
BRS Physiology |
2. First trimester
■The corpus luteum (stimulated by HCG) is responsible for the production of estradiol and progesterone.
■Peak levels of HCG occur at gestational week 9 and then decline.
3. Second and third trimesters
■Progesterone is produced by the placenta.
■Estrogens are produced by the interplay of the fetal adrenal gland and the placenta. The fetal adrenal gland synthesizes dehydroepiandrosterone-sulfate (DHEA-S), which is
then hydroxylated in the fetal liver. These intermediates are transferred to the placenta, where enzymes remove sulfate and aromatize to estrogens. The major placental estrogen is estriol.
■Human placental lactogen is produced throughout pregnancy. Its actions are similar to those of growth hormone and prolactin.
4. Parturition
■Throughout pregnancy, progesterone increases the threshold for uterine contraction.
■Near term, the estrogen/progesterone ratio increases, which makes the uterus more sensitive to contractile stimuli.
■The initiating event in parturition is unknown. (Although oxytocin is a powerful stimulant of uterine contractions, blood levels of oxytocin do not change before labor.)
5. Lactation
■Estrogens and progesterone stimulate the growth and development of the breasts throughout pregnancy.
■Prolactin levels increase steadily during pregnancy because estrogen stimulates prolactin secretion from the anterior pituitary.
■Lactation does not occur during pregnancy because estrogen and progesterone block the action of prolactin on the breast.
■After parturition, estrogen and progesterone levels decrease abruptly and lactation occurs.
■Lactation is maintained by suckling, which stimulates both oxytocin and prolactin secretion.
■Ovulation is suppressed as long as lactation continues because prolactin has the following effects:
a. Inhibits hypothalamic GnRH secretion.
b. Inhibits the action of GnRH on the anterior pituitary and consequently inhibits LH and FSH secretion.
c. Antagonizes the actions of LH and FSH on the ovaries.
Review Test
QUesTIOns 1–5
Use the graph below, which shows changes during the menstrual cycle, to answer Questions 1–5.
|
|
|
|
|
|
A |
|
|
|
|
|
|
|
|
|
B |
|
|
|
|
|
|
|
|
C |
D |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
E |
|
|
|
24 26 |
0 |
2 |
4 |
6 |
8 |
10 12 14 16 18 20 22 24 26 |
0 |
2 |
4 |
|
|
|
|
|
|
Day of cycle |
|
|
|
1. The increase shown at point A is caused by the effect of
(A)estrogen on the anterior pituitary
(B)progesterone on the hypothalamus
(C)follicle-stimulating hormone (FSH) on the ovary
(D)luteinizing hormone (LH) on the anterior pituitary
(e)prolactin on the ovary
2.Blood levels of which substance are described by curve B?
(A)Estradiol
(B)Estriol
(C)Progesterone
(D)Follicle-stimulating hormone (FSH)
(e) Luteinizing hormone (LH)
3. The source of the increase in concentration indicated at point C is the
(A)hypothalamus
(B)anterior pituitary
(C)corpus luteum
(D)ovary
(e)adrenal cortex
4.The source of the increase in concentration at point D is the
(A)ovary
(B)adrenal cortex
(C)corpus luteum
(D)hypothalamus
(e) anterior pituitary
5.The cause of the sudden increase shown at point E is
(A)negative feedback of progesterone on the hypothalamus
(B)negative feedback of estrogen on the anterior pituitary
(C)negative feedback of follicle-stimulating hormone (FSH) on the ovary
(D)positive feedback of FSH on the ovary
(e)positive feedback of estrogen on the anterior pituitary
6.A 41-year-old woman has hypocalcemia, hyperphosphatemia, and decreased urinary phosphate excretion. Injection of parathyroid hormone (PTH) causes an increase in urinary cyclic adenosine monophosphate (cAMP). The most likely diagnosis is
(A)primary hyperparathyroidism
(B)vitamin D intoxication
(C)vitamin D deficiency
(D)hypoparathyroidism after thyroid surgery
(e)pseudohypoparathyroidism
7.Which of the following hormones acts on its target tissues by a steroid hormone mechanism of action?
(A)Thyroid hormone
(B)Parathyroid hormone (PTH)
263
264 |
BRS Physiology |
(C) Antidiuretic hormone (ADH) on the collecting duct
(D) β1 adrenergic agonists
(E) Glucagon
8. A 38-year-old man who has galactorrhea is found to have a prolactinoma. His physician treats him with bromocriptine, which eliminates the galactorrhea. The basis for the therapeutic action of bromocriptine is that it
(A) antagonizes the action of prolactin on the breast
(B) enhances the action of prolactin on the breast
(C) inhibits prolactin release from the anterior pituitary
(D) inhibits prolactin release from the hypothalamus
(E) enhances the action of dopamine on the anterior pituitary
9. Which of the following hormones originates in the anterior pituitary?
(A) Dopamine
(B) Growth hormone–releasing hormone (GHRH)
(C) Somatostatin
(D) Gonadotropin-releasing hormone (GnRH)
(E) Thyroid-stimulating hormone (TSH)
(F) Oxytocin
(G) Testosterone
10. Which of the following functions of the Sertoli cells mediates negative feedback control of follicle-stimulating hormone (FSH) secretion?
(A) Synthesis of inhibin
(B) Synthesis of testosterone
(C) Aromatization of testosterone
(D) Maintenance of the blood–testes barrier
11. Which of the following substances is derived from proopiomelanocortin (POMC)?
(A) Adrenocorticotropic hormone (ACTH)
(B) Follicle-stimulating hormone (FSH)
(C) Melatonin
(D) Cortisol
(E) Dehydroepiandrosterone
12. Which of the following inhibits the secretion of growth hormone by the anterior pituitary?
(A) Sleep
(B) Stress
(C) Puberty
(D) Somatomedins
(E) Starvation
(F) Hypoglycemia
13. Selective destruction of the zona glomerulosa of the adrenal cortex would produce a deficiency of which hormone?
(A) Aldosterone
(B) Androstenedione
(C) Cortisol
(D) Dehydroepiandrosterone
(E) Testosterone
14. Which of the following explains the suppression of lactation during pregnancy?
(A) Blood prolactin levels are too low for milk production to occur
(B) Human placental lactogen levels are too low for milk production to occur
(C) The fetal adrenal gland does not produce sufficient estriol
(D) Blood levels of estrogen and progesterone are high
(E) The maternal anterior pituitary is suppressed
15. Which step in steroid hormone biosynthesis, if inhibited, blocks the production of all androgenic compounds but does not block the production of glucocorticoids?
(A) Cholesterol → pregnenolone
(B) Progesterone → 11-deoxycorticosterone
(C) 17-Hydroxypregnenolone → dehydroepiandrosterone
(D) Testosterone → estradiol
(E) Testosterone → dihydrotestosterone
16. A 46-year-old woman has hirsutism, hyperglycemia, obesity, muscle wasting, and increased circulating levels of adrenocorticotropic hormone (ACTH). The most likely cause of her symptoms is
(A) primary adrenocortical insufficiency (Addison disease)
(B) pheochromocytoma
(C) primary overproduction of ACTH (Cushing disease)
(D) treatment with exogenous glucocorticoids
(E) hypophysectomy
17. Which of the following decreases the conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol?
(A) A diet low in Ca2+
(B) Hypocalcemia
(C) Hyperparathyroidism
(D) Hypophosphatemia
(E) Chronic renal failure
18. Increased adrenocorticotropic hormone (ACTH) secretion would be expected in patients
(A) with chronic adrenocortical insufficiency (Addison disease)
(B) with primary adrenocortical hyperplasia
(C) who are receiving glucocorticoid for immunosuppression after a renal transplant
(D) with elevated levels of angiotensin II
19. Which of the following would be expected in a patient with Graves disease?
(A) Cold sensitivity
(B) Weight gain
(C) Decreased O2 consumption
(D) Decreased cardiac output
(E) Drooping eyelids
(F) Atrophy of the thyroid gland
(G) Increased thyroid-stimulating hormone (TSH) levels
(H) Increased triiodothyronine (T3) levels
20. Blood levels of which of the following substances is decreased in Graves disease?
(A) Triiodothyronine (T3)
(B) Thyroxine (T4)
(C) Diiodotyrosine (DIT)
(D) Thyroid-stimulating hormone (TSH)
(E) Iodide (I−)
21. Which of the following hormones acts by an inositol 1,4,5-triphosphate (IP3)-Ca2+ mechanism of action?
(A) 1,25-Dihydroxycholecalciferol
(B) Progesterone
(C) Insulin
(D) Parathyroid hormone (PTH)
(E) Gonadotropin-releasing hormone (GnRH)
22. Which step in steroid hormone biosynthesis is stimulated by adrenocorticotropic hormone (ACTH)?
|
Endocrine Physiology |
265 |
Chapter 7 |
(A) Cholesterol → pregnenolone
(B) Progesterone → 11-deoxycorticosterone
(C) 17-Hydroxypregnenolone → dehydroepiandrosterone
(D) Testosterone → estradiol
(E) Testosterone → dihydrotestosterone
23. The source of estrogen during the second and third trimesters of pregnancy is the
(A) corpus luteum
(B) maternal ovaries
(C) fetal ovaries
(D) placenta
(E) maternal ovaries and fetal adrenal gland
(F) maternal adrenal gland and fetal liver
(G) fetal adrenal gland, fetal liver, and placenta
24. Which of the following causes increased aldosterone secretion?
(A) Decreased blood volume
(B) Administration of an inhibitor of angiotensin-converting enzyme (ACE)
(C) Hyperosmolarity
(D) Hypokalemia
25. Secretion of oxytocin is increased by
(A) milk ejection
(B) dilation of the cervix
(C) increased prolactin levels
(D) increased extracellular fluid (ECF) volume
(E) increased serum osmolarity
26. A 61-year-old woman with hyperthyroidism is treated with propylthiouracil. The drug reduces the synthesis of thyroid hormones because it inhibits oxidation of
(A) Triiodothyronine (T3)
(B) Thyroxine (T4)
(C) Diiodotyrosine (DIT)
(D) Thyroid-stimulating hormone (TSH)
(E) Iodide (I−)
27. A 39-year-old man with untreated diabetes mellitus type I is brought to the emergency room. An injection of insulin would be expected to cause an increase in his
(A) urine glucose concentration
(B) blood glucose concentration
(C) blood K+ concentration
(D) blood pH
(E) breathing rate
266 |
BRS Physiology |
28. Which of the following results from the action of parathyroid hormone (PTH) on the renal tubule?
(A) Inhibition of 1α-hydroxylase
(B) Stimulation of Ca2+ reabsorption in the distal tubule
(C) Stimulation of phosphate reabsorption in the proximal tubule
(D) Interaction with receptors on the luminal membrane of the proximal tubular cells
(E) Decreased urinary excretion of cyclic adenosine monophosphate (CAMP)
29. Which step in steroid hormone biosynthesis occurs in the accessory sex target tissues of the male and is catalyzed by 5α-reductase?
(A) Cholesterol → pregnenolone
(B) Progesterone → 11-deoxycorticosterone
(C) 17-Hydroxypregnenolone → dehydroepiandrosterone
(D) Testosterone → estradiol
(E) Testosterone → dihydrotestosterone
30. Which of the following pancreatic secretions has a receptor with four subunits, two of which have tyrosine kinase activity?
(A) Insulin
(B) Glucagon
(C) Somatostatin
(D) Pancreatic lipase
31. A 16-year-old, seemingly normal female is diagnosed with androgen insensitivity disorder. She has never had a menstrual cycle and is found to have a blind-ending vagina; no uterus, cervix, or ovaries; a 46 XY genotype; and intra-abdominal testes. Her serum testosterone is elevated. Which of the
following characteristics is caused by lack of androgen receptors?
(A) 46 XY genotype
(B) Testes
(C) Elevated serum testosterone
(D) Lack of uterus and cervix
(E) Lack of menstrual cycles